PGR and breast cancer: Nevertheless, it is unlikely that receptor status conversion in our cohort is solely attributable to technical issues, as differences in OS depending on the ER and PR are biologically meaningful observations given the superior prognosis of hormone receptor-positive breast cancers [32].